Skip to main content

Published locations for High-risk MDS: Stanozolol improves PFS after effective induction therapy with decitabine

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. High-risk MDS: Stanozolol improves PFS after effective induction therapy with decitabine

User login

  • Reset your password
  • /content/high-risk-mds-stanozolol-improves-pfs-after-effective-induction-therapy-decitabine
  • /hematology-oncology/article/238084/myelodysplastic-syndrome/high-risk-mds-stanozolol-improves-pfs